A pilot study of an investigational testosterone transdermal patch system in young women with spontaneous premature ovarian failure

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 12, 2005, Pages 6549-6552

  Kalantaridou, Sophia N ^a   Calis, Karim A ^b   Mazer, Norman A ^c   Godoy, Heidy ^a   Nelson, Lawrence M ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GESTAGEN; MEDROXYPROGESTERONE ACETATE; TESTOSTERONE;

ADULT; ARTICLE; BLEEDING; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HORMONE SYNTHESIS; HUMAN; PILOT STUDY; PREMATURE OVARIAN FAILURE; PREMENOPAUSE; PRIORITY JOURNAL; STEADY STATE; TESTOSTERONE BLOOD LEVEL;

ADMINISTRATION, CUTANEOUS; ADULT; ANDROGENS; FEMALE; HORMONES; HUMANS; MENSTRUAL CYCLE; OVARIAN FAILURE, PREMATURE; PILOT PROJECTS; TESTOSTERONE;

EID: 28744434744     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-0692     Document Type: Article

References (18)

1. Abraham GE 1974 Ovarian and adrenal contribution to peripheral androgens during the menstrual cycle. J Clin Endocrinol Metab 39:340-346
2. Judd HL, Lucas WE, Yen SS 1974 Effect of oophorectomy on circulating testosterone and androstenedione levels in patients with endometrial cancer. Am J Obstet Gynecol 118:793-798
3. Bermudez JA, Moran C, Herrera J, Barahona E, Perez MC, Zarate A 1993 Determination of the steroidogenic capacity in premature ovarian failure. Fertil Steril 60:668-671
4. Doldi N, Belvisi L, Bassan M, Fusi FM, Ferrari A 1998 Premature ovarian failure: steroid synthesis and autoimmunity. Gynecol Endocrinol 12:23-28
5. Hartmann BW, Kirchengast S, Albrecht A, Laml T, Soregi G, Huber JC 1997 Androgen serum levels in women with premature ovarian failure compared to fertile and menopausal controls. Gynecol Obstet Invest 44:127-131
6. Kim TJ, Anasti JN, Flack MR, Kimzey LM, Defensor RA, Nelson LM 1997 Routine endocrine screening for patients with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 89:777-779
7. Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon S 1998 Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab 83:2717-2725
8. Javanbakht M, Singh AB, Mazer NA, Beall G, Sinha-Hikim I, Shen R, Bhasin S 2000 Pharmacokinetics of a novel testosterone matrix transdermal system in health, premenopausal women and women infected with human immunodeficiency syndrome. J Clin Endocrinol Metab 85:2395-2401
9. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA 2000 Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 343:682-688
10. Ferriman D, Gallwey JD 1961 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440-1447
11. Anasti JN, Kalantaridou SN, Kimzey LM, Defensor RA, Nelson LM 1998 Bone loss in young women with karyotypically normal spontaneous premature ovarian failure. Obstet Gynecol 91:12-15
12. Davis SR, McCloud P, Strauss BJG, Burger H 1995 Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 21:227-236
13. Barrett-Connor E, Young R, Notelovitz M, Sullivan J, Wiita B, Hwa-Ming Y, Nolan J 1999 A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. J Reprod Med 44:1012-1020
14. Savvas M, Studd JW, Norman S, Leather AT, Garnett TJ, Fogelman I 1992 Increase in bone mass after one year of percutaneous and oestradiol implants in post-menopausal women who have previously received long-term oral oestrogens. Brit J Obstet Gynaecol 99:757-760
15. Mazer NA, Shifren JL 2003 Transdermal testosterone for women: a new physiological approach for androgen therapy. Obstet Gynecol Surv 58:489-500
16. Rosner W 1990 The functions of corticosteroid-binding globulin and sexhormone binding globulin: recent advances. Endocr Rev 11:80-91
17. Chetkowski RJ, Meldrum DR, Steingold KA, Randle D, Lu JK, Eggena P, Hershman JM, Alkjaersig NK, Fletcher AP, Judd HL 1986 Biologic effects of transdermal estradiol. N Engl J Med 314:1615-1620
18. Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK 2003 Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Clin Endocrinol (Oxf) 59:690-698